Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Jasmin Sabrina Rast, Theresa Schramm, Dino Mehic, Michelle Fuchs, Michael Fillitz, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 1208.

https://doi.org/10.1182/blood-2023-185866

Published: 2023

Journal Articles

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Dino Mehic, Daniel Kraemmer, Jasmin Sabrina Rast, Silvia Koder, Michelle Fuchs, Helmuth Haslacher, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 1249.

https://doi.org/10.1182/blood-2023-185843

Published: 2023

Journal Articles

Utility of the Platelet Function Analyzer (PFA-100) in Patients with Bleeding Disorder of Unknown Cause

Dino Mehic, Jasmin Sabrina Rast, Michelle Fuchs, Alexander Tolios, Beate Eichelberger, Alexandra Kaider, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2023) 142 (Supplement 1): 3965.

https://doi.org/10.1182/blood-2023-185756

Published: 2023

Journal Articles

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer, Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma-Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Beliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger

Blood (2023) 141 (10): 1147–1158.

https://doi.org/10.1182/blood.2022016571

Published: 2023

Includes: Supplemental data

Journal Articles

Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer

Florian Moik, Simon Kraler, Fabrizio Montecucco, Luca Liberale, Stephan Nopp, Cornelia Englisch, Tetiana Lapikova-Bryhinska, Alexander Akhmedov, Arnold von Eckardstein, Florian A. Wenzl, Ingrid Pabinger, Thomas F. Lüscher, Cihan Ay

Blood (2022) 140 (Supplement 1): 1255–1256.

https://doi.org/10.1182/blood-2022-163287

Published: 2022

Journal Articles

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Florian Moik, Jakob Riedl, Dominik Barth, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Höller, Thorsten Fuereder, Philipp Jost, Ingrid Pabinger, Matthias Preusser, Cihan Ay

Blood (2022) 140 (Supplement 1): 1250–1251.

https://doi.org/10.1182/blood-2022-160087

Published: 2022

Journal Articles

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Dino Mehic, Daniel Kraemmer, Alexander Tolios, Julia Bücheler, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2022) 140 (Supplement 1): 8433–8434.

https://doi.org/10.1182/blood-2022-158959

Published: 2022

Journal Articles

Impact of ABO Blood Group Type on Risk of Venous Thromboembolism in Patients with Cancer

Cornelia Englisch, Florian Moik, Stephan Nopp, Markus Raderer, Ingrid Pabinger, Cihan Ay

Blood (2021) 138 (Supplement 1): 2119.

https://doi.org/10.1182/blood-2021-145713

Published: 2021

Journal Articles

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Meaghan Colling, Florian Posch, Silvia Koder, Peter Quehenberger, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2021) 138 (Supplement 1): 290.

https://doi.org/10.1182/blood-2021-148365

Published: 2021

Journal Articles

Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP)

Theresa Schramm, Jennifer Machacek, Michael Fillitz, Barbara Dixer, Peter Quehenberger, Dino Mehic, Cihan Ay, Ingrid Pabinger, Johanna Gebhart

Blood (2021) 138 (Supplement 1): 3162.

https://doi.org/10.1182/blood-2021-152261

Published: 2021

Journal Articles

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Hoeller, Felix Tuchmann, Marie-Bernadette Aretin, Thorsten Fuereder, Sabine Zöchbauer-Müller, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood (2021) 137 (12): 1669–1678.

https://doi.org/10.1182/blood.2020007878

Published: 2021

Includes: Supplemental data

Journal Articles

Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis

Georg Obermayer, Taras Afonyushkin, Laura Göderle, Florian Puhm, Waltraud Schrottmaier, Soreen Taqi, Michael Schwameis, Cihan Ay, Ingrid Pabinger, Bernd Jilma, Alice Assinger, Nigel Mackman, Christoph J. Binder

Blood (2021) 137 (10): 1406–1415.

https://doi.org/10.1182/blood.2020007155

Published: 2021

Includes: Supplemental data

Journal Articles

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Florian Moik, MD, Gerald Prager, MD, Sarah Wiedemann, Florian Posch, MD MSc, PhD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141239

Published: 2020

Journal Articles

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Dino Mehic, MD, Stefanie Hofer, PhD, Christof Jungbauer, MD, Alexandra Kaider, Helmuth Haslacher, MD, Ernst Eigenbauer, Judit Rejtoe, MD, Dieter Schwartz, MD, Bernd Jilma, Cihan Ay, MD, Ingrid Pabinger, MD, Johanna Gebhart, MD PhD

Blood (2020) 136 (Supplement 1): 16–18.

https://doi.org/10.1182/blood-2020-137378

Published: 2020

Journal Articles

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Judit Rejtoe, MD, Oliver Königsbrügge, MD, Ella Grilz, MD, Stefanie Hofer, Johanna Gebhart, MD, Gerhard Schuster, MD, Clemens Feistritzer, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2019) 134 (Supplement_1): 1135.

https://doi.org/10.1182/blood-2019-123187

Published: 2019

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

Paul Knoebl, MD, Wolfgang R. Sperr, Peter Schellongowski, MD, Thomas Staudinger, MD, Petra Jilma-Stohlawetz, MD, Peter Quehenberger, MD, Silvia Koder, Ing, Cihan Ay, MD, Karoline V. Gleixner, MD

Blood (2018) 132 (Supplement 1): 2476.

https://doi.org/10.1182/blood-2018-99-116973

Published: 2018

Journal Articles

The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis

Ella Grilz, MD, Lisa-Marie Mauracher, MSc, Oliver Königsbrügge, MD PhD, Florian Posch, MD MSc, Irene Lang, MD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2018) 132 (Supplement 1): 2508.

https://doi.org/10.1182/blood-2018-99-116104

Published: 2018

Journal Articles

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Florian Posch, MD MSc, Julia Riedl, MD, Eva-Maria Reitter, MD, Peter Quehenberger, MD, Cihan Ay, MD, Ingrid Pabinger, MD

Blood (2017) 130 (Supplement 1): 1095.

https://doi.org/10.1182/blood.V130.Suppl_1.1095.1095

Published: 2017

Journal Articles

Tissue Factor-Related Biomarkers and Prediction of Cancer-Associated VTE: Correlative Analyses of the Phacs Trial

Alok A. Khorana, MD, Nigel Mackman, PhD, Yohei Hisada, PhD, Cihan Ay, MD, Derick Peterson, Charles W. Francis, MD, Andrea Baran, MS

Blood (2017) 130 (Supplement 1): 1096.

https://doi.org/10.1182/blood.V130.Suppl_1.1096.1096

Published: 2017

Journal Articles

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Julia Riedl, Matthias Preusser, Pegah Mir Seyed Nazari, Florian Posch, Simon Panzer, Christine Marosi, Peter Birner, Johannes Thaler, Christine Brostjan, Daniela Lötsch, Walter Berger, Johannes A. Hainfellner, Ingrid Pabinger, Cihan Ay

Blood (2017) 129 (13): 1831–1839.

https://doi.org/10.1182/blood-2016-06-720714

Published: 2017

Includes: Supplemental data

NARROW

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Utility of the Platelet Function Analyzer (PFA-100) in Patients with Bleeding Disorder of Unknown Cause

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Impact of ABO Blood Group Type on Risk of Venous Thromboembolism in Patients with Cancer

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP)

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Natural IgM antibodies inhibit microvesicle-driven coagulation and thrombosis

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

The Role of Neutrophil Extracellular Traps in Cancer-Associated Arterial Thrombosis

Longitudinal Haemostatic Biomarker Trajectories Predict Cancer-Associated Venous Thromboembolism

Tissue Factor-Related Biomarkers and Prediction of Cancer-Associated VTE: Correlative Analyses of the Phacs Trial

Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only